Abstral
Product Images NDC 42747-221

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Abstral (NDC 42747-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prostrakan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abstral-01 (Abstral 01)

This is a dosage titration process for ABSTRAL, a medication used for breakthrough pain. The initial dose is 100 meg and subsequent doses are adjusted according to a table provided. Adequate pain relief should be achieved within 30 minutes, and subsequent doses should be separated by at least 2 hours. The table provides dosing instructions for various doses from 200 meg to 800 meg.*

FDA Label Image

Abstral-02 (Abstral 02)

FDA Label Image

Abstral-03 (Abstral 03)

FDA Label Image

Abstral-04 (Abstral 04)

The text is not-available as it consists of random characters and unidentifiable symbols.*

FDA Label Image

Abstral-05 (Abstral 05)

FDA Label Image

Abstral-06 (Abstral 06)

FDA Label Image

Abstral-07 (Abstral 07)

FDA Label Image

Abstral-08 (Abstral 08)

FDA Label Image

Abstral-09 (Abstral 09)

ABSTRAL®G is a medication that comes in the form of sublingual tablets containing fentanyl. It is not recommended to swallow the tablet whole and it can only be administered sublingually. The text also includes a reference number and contact information for questions. However, due to errors and non-English characters, the text is not very clear.*

FDA Label Image

Abstral-10 (Abstral 10)

ABSTRAL is a medication in the form of sublingual tablets containing fentanyl, used for management of breakthrough cancer pain in adults who are regularly taking opioids. The text also includes some unreadable characters and symbols.*

FDA Label Image

Abstral-11 (Abstral 11)

This is for a medication called ABSTRAL, which is a fentanyl sublingual tablet used for pain management. The text includes dosage and safety information, as well as contact details for questions or concerns.*

FDA Label Image

Abstral-12 (Abstral 12)

ABSTRAL is a brand name of sublingual fentanyl tablets indicated for the management of breakthrough cancer pain in opioid-tolerant patients. The text also includes product information such as dosage, strength, and administration instructions.*

FDA Label Image

Abstral-13 (Abstral 13)

ABSTRAL® is a sublingual tablet containing fentanyl, produced by Novartis. It is equivalent to ERTORRYSR, and each tablet contains 22 subtngos Tavts. The tablet should not be chewed or swallowed whole. The rest of the text is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.